Q4 was meant to be a very strong quarter, with many commenting that with Covid headwinds largely absent in the US … so when it comes in softer than Q3 it raises questions in the growth trajectory.
PNV at $1.50- $2 was priced to grow very strongly, nudging triple figure annual sales growth in the coming year or two… market clearly disappointed and will again wait and see if the promised growth accelerates in FY23 or remains mid double digits.
costs don’t like to be discussed here, but suffice to say it needs to tightly controlled in the coming 12 -24 months and revenue needs to outstrip cost growth by a fair bit to deliver profits. Something they’ve failed to do thus far.
Ann: FY22 Results Presentation, page-244
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.07 |
Change
0.030(1.47%) |
Mkt cap ! $1.429B | |||
| Open | High | Low | Value | Volume |
| $2.11 | $2.12 | $2.05 | $2.783M | 1.335M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 19976 | $2.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.07 | 9633 | 3 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| PNV (ASX) Chart |